Testing several genes can provide precise knowledge about the choice of right...
Most of us have genetic variations that increase the risk of medicinal products not being effective. In order to provide a more effective treatment with fewer side effects, we need to analyse more of...
View ArticleAsthmatic children who are overweight or obese less likely to respond to...
Asthmatic children are less likely to respond to inhaled steroid medication if they are overweight or obese, and this leads to more frequent asthma attacks, according to research presented at the...
View ArticleStudy pinpoints a potential pathway for treating epileptic seizures in...
Autism affects about 2% of children in the United States, and about 30% of these children have seizures. Recent large-scale genetic studies revealed that genetic variants in a sodium channel, called...
View ArticleWorld renowned medical oncologist joins Henry Ford Cancer Institute
Internationally renowned medical oncologist Philip A. Philip, M.D., Ph.D., has joined Henry Ford Cancer Institute as director of Gastrointestinal Oncology and Neuroendocrine Oncology, medical director...
View ArticleStudy shows clinical value of pharmacogenomic testing for patients with...
Pharmacogenetic testing was associated with nearly a two-fold (89 per cent) increase in remission rates compared to treatment as usual in a Centre for Addiction and Mental Health- (CAMH-)led clinical...
View ArticleNovel rapid genetic test could spare 14,000 newborns from lifelong hearing loss
Clinicians and nurses in neonatal intensive care units (NICU) across Manchester University NHS Foundation Trust (MFT) are the world’s first to deploy genedrive’s MT-RNR1 ID Kit, a new rapid genetic...
View ArticleStudy evaluates benefits of implementing a pharmacogenetic panel before drug...
In a recent study published in The Lancet, researchers performed an implementation study of a 12-gene pharmacogenetic panel across seven European countries to investigate whether a gene-drug...
View ArticleStudy to measure the impact of whole genome sequencing in patients with...
Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of...
View ArticleAMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays
The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical...
View ArticlePharmacogenomics holds promise for personalized dementia therapies
Pharmacogenomics-based studies in the research for personalized therapeutics for dementia
View Article
